BioSpace News Archive

Mirum Pharmaceuticals, Inc. today announced that it will participate in Piper Sandler’s Virtual European Association for the Study of the Liver (EASL) Takeaway Day on Monday, June 28, 2021, at 2:00 p.m. ET.

Quantum-Si Incorporated, a company pioneering next-generation semiconductor chip-based proteomics, announced today that it has entered into a lease agreement with Phase 3 Real Estate Partners, Inc. to develop a 25,586-square-foot product development and operations facility in San Diego, CA.

As COVID-19 activity continues in Canada, we are tracking a range of epidemiological indicators to monitor where the disease is most active, where it is spreading and how it is impacting the health of Canadians and public health, laboratory and healthcare capacity.

Zenith Capital Corp. announces the publication of an important study which has uncovered the role of ZEN-3694.

Monopar Therapeutics Inc. today announced that it will present its oropharyngeal cancer (OPC) patient population analysis of the Phase 2 Validive ® (clonidine HCl MBT) trial for the prevention of chemoradiotherapy-induced severe oral mucositis in head and neck cancer.

Optinose, a pharmaceutical company focused on patients treated by ear, nose and throat and allergy specialists, announced Dr. Per Djupesland received the European Inventor Award 2021 in the Industry category from the European Patent Office for his invention of the technology that serves as a basis for the Optinose Exhalation Delivery System.

In many situations, heart muscle cells do not respond to external stresses in the same ways that skeletal muscle cells do.

HUYABIO International announced today that HBI-8000 will be marketed under the brand name Hiyasta ™ in Japan .

Neurent Medical today announced expansions of its leadership team.

IM Therapeutics, Inc. announced today that Peter Gottlieb, M.D., Co-founder and Chief Medical Officer, will present at the American Diabetes Association (ADA) 81 st Scientific Sessions, held June 25-29, 2021.